

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | phospholipid efflux (GO:0033700) | 9.60529402 |
| 2 | high-density lipoprotein particle remodeling (GO:0034375) | 9.27101995 |
| 3 | regulation of triglyceride catabolic process (GO:0010896) | 8.71225069 |
| 4 | reverse cholesterol transport (GO:0043691) | 8.08258421 |
| 5 | plasma lipoprotein particle assembly (GO:0034377) | 7.42216690 |
| 6 | very-low-density lipoprotein particle assembly (GO:0034379) | 6.80730457 |
| 7 | protein-lipid complex assembly (GO:0065005) | 6.47325433 |
| 8 | regulation of cholesterol esterification (GO:0010872) | 6.28875693 |
| 9 | cholesterol efflux (GO:0033344) | 5.83479671 |
| 10 | protein-lipid complex remodeling (GO:0034368) | 5.63974232 |
| 11 | macromolecular complex remodeling (GO:0034367) | 5.63974232 |
| 12 | plasma lipoprotein particle remodeling (GO:0034369) | 5.63974232 |
| 13 | negative regulation of lipase activity (GO:0060192) | 5.14814037 |
| 14 | DNA damage response, detection of DNA damage (GO:0042769) | 5.02699421 |
| 15 | transepithelial transport (GO:0070633) | 4.72518638 |
| 16 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.72332118 |
| 17 | lipoprotein transport (GO:0042953) | 4.55190779 |
| 18 | negative regulation of sterol transport (GO:0032372) | 4.48053282 |
| 19 | negative regulation of cholesterol transport (GO:0032375) | 4.48053282 |
| 20 | water-soluble vitamin biosynthetic process (GO:0042364) | 4.41284334 |
| 21 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 4.23147028 |
| 22 | plasma lipoprotein particle organization (GO:0071827) | 4.19837555 |
| 23 | ovulation from ovarian follicle (GO:0001542) | 4.14746347 |
| 24 | regulation of lipoprotein metabolic process (GO:0050746) | 4.06977494 |
| 25 | DNA double-strand break processing (GO:0000729) | 3.99804352 |
| 26 | plasma lipoprotein particle clearance (GO:0034381) | 3.90539229 |
| 27 | protein-lipid complex subunit organization (GO:0071825) | 3.87616817 |
| 28 | removal of superoxide radicals (GO:0019430) | 3.80106634 |
| 29 | cellular response to superoxide (GO:0071451) | 3.80106634 |
| 30 | cellular response to oxygen radical (GO:0071450) | 3.80106634 |
| 31 | polyol transport (GO:0015791) | 3.77759664 |
| 32 | glial cell proliferation (GO:0014009) | 3.69456852 |
| 33 | cellular response to nitric oxide (GO:0071732) | 3.68381261 |
| 34 | negative regulation of receptor-mediated endocytosis (GO:0048261) | 3.55770727 |
| 35 | cellular response to zinc ion (GO:0071294) | 3.52880121 |
| 36 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.45111492 |
| 37 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.45111492 |
| 38 | response to phenylpropanoid (GO:0080184) | 3.40941028 |
| 39 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 3.37589597 |
| 40 | centriole replication (GO:0007099) | 3.22995962 |
| 41 | regulation of lipoprotein particle clearance (GO:0010984) | 3.22490947 |
| 42 | triglyceride homeostasis (GO:0070328) | 3.21176949 |
| 43 | acylglycerol homeostasis (GO:0055090) | 3.21176949 |
| 44 | negative regulation of DNA-dependent DNA replication (GO:2000104) | 3.20648165 |
| 45 | response to hydroperoxide (GO:0033194) | 3.19853836 |
| 46 | negative regulation of DNA recombination (GO:0045910) | 3.15898636 |
| 47 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 3.15440156 |
| 48 | regulation of translation, ncRNA-mediated (GO:0045974) | 3.15440156 |
| 49 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 3.15440156 |
| 50 | replication fork processing (GO:0031297) | 3.11997257 |
| 51 | regulation of triglyceride metabolic process (GO:0090207) | 3.11822085 |
| 52 | DNA ligation (GO:0006266) | 3.06433673 |
| 53 | C4-dicarboxylate transport (GO:0015740) | 3.05393977 |
| 54 | respiratory chain complex IV assembly (GO:0008535) | 3.03370597 |
| 55 | cholesterol transport (GO:0030301) | 3.02307566 |
| 56 | sterol transport (GO:0015918) | 3.02307566 |
| 57 | protein carboxylation (GO:0018214) | 2.94600689 |
| 58 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.94600689 |
| 59 | positive regulation of glycoprotein metabolic process (GO:1903020) | 2.94036539 |
| 60 | vitamin A metabolic process (GO:0006776) | 2.92303567 |
| 61 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 2.83286058 |
| 62 | phototransduction, visible light (GO:0007603) | 2.82308136 |
| 63 | regulation of protein glycosylation (GO:0060049) | 2.82008194 |
| 64 | response to superoxide (GO:0000303) | 2.79830752 |
| 65 | cellular response to reactive nitrogen species (GO:1902170) | 2.78716981 |
| 66 | regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266) | 2.78562467 |
| 67 | regulation of mitotic spindle checkpoint (GO:1903504) | 2.78562467 |
| 68 | maintenance of fidelity involved in DNA-dependent DNA replication (GO:0045005) | 2.77085994 |
| 69 | microtubule anchoring (GO:0034453) | 2.77030609 |
| 70 | mechanosensory behavior (GO:0007638) | 2.75153112 |
| 71 | negative regulation of lipid catabolic process (GO:0050995) | 2.72597134 |
| 72 | L-ascorbic acid metabolic process (GO:0019852) | 2.71322629 |
| 73 | cytochrome complex assembly (GO:0017004) | 2.71071718 |
| 74 | homocysteine metabolic process (GO:0050667) | 2.70300711 |
| 75 | DNA replication-dependent nucleosome organization (GO:0034723) | 2.70265818 |
| 76 | DNA replication-dependent nucleosome assembly (GO:0006335) | 2.70265818 |
| 77 | sulfation (GO:0051923) | 2.70094391 |
| 78 | regulation of lipoprotein lipase activity (GO:0051004) | 2.64856374 |
| 79 | lipoprotein metabolic process (GO:0042157) | 2.62272778 |
| 80 | double-strand break repair via nonhomologous end joining (GO:0006303) | 2.62027246 |
| 81 | non-recombinational repair (GO:0000726) | 2.62027246 |
| 82 | telomere maintenance via telomerase (GO:0007004) | 2.60893800 |
| 83 | detection of visible light (GO:0009584) | 2.59533539 |
| 84 | neutral lipid catabolic process (GO:0046461) | 2.59156888 |
| 85 | acylglycerol catabolic process (GO:0046464) | 2.59156888 |
| 86 | glutathione derivative biosynthetic process (GO:1901687) | 2.59016504 |
| 87 | glutathione derivative metabolic process (GO:1901685) | 2.59016504 |
| 88 | chromatin remodeling at centromere (GO:0031055) | 2.57024236 |
| 89 | sperm capacitation (GO:0048240) | 2.55895479 |
| 90 | glutamine metabolic process (GO:0006541) | 2.55323819 |
| 91 | retinal cone cell development (GO:0046549) | 2.55138897 |
| 92 | presynaptic membrane assembly (GO:0097105) | 2.52013555 |
| 93 | response to oxygen radical (GO:0000305) | 2.51745509 |
| 94 | cholesterol homeostasis (GO:0042632) | 2.51568314 |
| 95 | retinoid metabolic process (GO:0001523) | 2.48583876 |
| 96 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 2.47243538 |
| 97 | phototransduction (GO:0007602) | 2.47149311 |
| 98 | sulfate transmembrane transport (GO:1902358) | 2.46903570 |
| 99 | sterol homeostasis (GO:0055092) | 2.46284563 |
| 100 | anterograde synaptic vesicle transport (GO:0048490) | 2.43763470 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 4.53787013 |
| 2 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.39495240 |
| 3 | IGF1R_20145208_ChIP-Seq_DFB_Human | 3.06555573 |
| 4 | VDR_22108803_ChIP-Seq_LS180_Human | 2.82071362 |
| 5 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.63373652 |
| 6 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.48306247 |
| 7 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.46927524 |
| 8 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 2.45872629 |
| 9 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.40924389 |
| 10 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.30254397 |
| 11 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.26208734 |
| 12 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.17726486 |
| 13 | P300_19829295_ChIP-Seq_ESCs_Human | 2.16576810 |
| 14 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.09295967 |
| 15 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.08567170 |
| 16 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.06470200 |
| 17 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.00166304 |
| 18 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.99248930 |
| 19 | FUS_26573619_Chip-Seq_HEK293_Human | 1.96821948 |
| 20 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.93869610 |
| 21 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.91765767 |
| 22 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.79920204 |
| 23 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.76409367 |
| 24 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.75383157 |
| 25 | EWS_26573619_Chip-Seq_HEK293_Human | 1.75242288 |
| 26 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.68928826 |
| 27 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.65164855 |
| 28 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.62605138 |
| 29 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.61663853 |
| 30 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.59774143 |
| 31 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.59006423 |
| 32 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.58060819 |
| 33 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.56153778 |
| 34 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.55479820 |
| 35 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.54737958 |
| 36 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.53583853 |
| 37 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.52970613 |
| 38 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.52546058 |
| 39 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.50976106 |
| 40 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.50131861 |
| 41 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.49648611 |
| 42 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.43648371 |
| 43 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.41146299 |
| 44 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.40072880 |
| 45 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.40072880 |
| 46 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.39779469 |
| 47 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.39309585 |
| 48 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.39223003 |
| 49 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.35979362 |
| 50 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.35536345 |
| 51 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.34317086 |
| 52 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.33439258 |
| 53 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.32562592 |
| 54 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.32311813 |
| 55 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.28034358 |
| 56 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.24886167 |
| 57 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 1.23367550 |
| 58 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.23323048 |
| 59 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.23323048 |
| 60 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.22907823 |
| 61 | STAT3_23295773_ChIP-Seq_U87_Human | 1.22533132 |
| 62 | AR_25329375_ChIP-Seq_VCAP_Human | 1.21599585 |
| 63 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.20280868 |
| 64 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.16894381 |
| 65 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.14825982 |
| 66 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.14706813 |
| 67 | TCF4_23295773_ChIP-Seq_U87_Human | 1.14665728 |
| 68 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.14508091 |
| 69 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.12772914 |
| 70 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.12151089 |
| 71 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.12121262 |
| 72 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.11329534 |
| 73 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.10957968 |
| 74 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.10154748 |
| 75 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.09911223 |
| 76 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.09357002 |
| 77 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.09192098 |
| 78 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.08827948 |
| 79 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.08243790 |
| 80 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.08187370 |
| 81 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.07709050 |
| 82 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.07402649 |
| 83 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.06805242 |
| 84 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.05668283 |
| 85 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.05668283 |
| 86 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.05470120 |
| 87 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 1.05371100 |
| 88 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.04785962 |
| 89 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.04489084 |
| 90 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.02826922 |
| 91 | JUN_21703547_ChIP-Seq_K562_Human | 1.02617916 |
| 92 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.02094635 |
| 93 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.01654565 |
| 94 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.01461364 |
| 95 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.01461364 |
| 96 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 0.98550907 |
| 97 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.97675979 |
| 98 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 0.97296290 |
| 99 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 0.97241517 |
| 100 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 0.95826150 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0009840_abnormal_foam_cell | 7.78980612 |
| 2 | MP0004270_analgesia | 4.28285622 |
| 3 | MP0005360_urolithiasis | 4.06671243 |
| 4 | MP0001188_hyperpigmentation | 3.59854530 |
| 5 | MP0003878_abnormal_ear_physiology | 3.26723320 |
| 6 | MP0005377_hearing/vestibular/ear_phenot | 3.26723320 |
| 7 | MP0003941_abnormal_skin_development | 2.65383385 |
| 8 | MP0002254_reproductive_system_inflammat | 2.27898795 |
| 9 | MP0003718_maternal_effect | 2.26342797 |
| 10 | MP0006072_abnormal_retinal_apoptosis | 2.24480515 |
| 11 | MP0000569_abnormal_digit_pigmentation | 2.23989619 |
| 12 | MP0008877_abnormal_DNA_methylation | 2.07309110 |
| 13 | MP0002734_abnormal_mechanical_nocicepti | 2.05916137 |
| 14 | MP0008058_abnormal_DNA_repair | 1.98124529 |
| 15 | MP0001485_abnormal_pinna_reflex | 1.97813065 |
| 16 | MP0010329_abnormal_lipoprotein_level | 1.95792667 |
| 17 | MP0004145_abnormal_muscle_electrophysio | 1.95136626 |
| 18 | MP0004019_abnormal_vitamin_homeostasis | 1.93577492 |
| 19 | MP0003136_yellow_coat_color | 1.92580845 |
| 20 | MP0005551_abnormal_eye_electrophysiolog | 1.88599459 |
| 21 | MP0002938_white_spotting | 1.85494590 |
| 22 | MP0005367_renal/urinary_system_phenotyp | 1.70500819 |
| 23 | MP0000516_abnormal_urinary_system | 1.70500819 |
| 24 | MP0010094_abnormal_chromosome_stability | 1.60840745 |
| 25 | MP0001293_anophthalmia | 1.59731483 |
| 26 | MP0004142_abnormal_muscle_tone | 1.58034366 |
| 27 | MP0003567_abnormal_fetal_cardiomyocyte | 1.48134336 |
| 28 | MP0003880_abnormal_central_pattern | 1.47085706 |
| 29 | MP0002876_abnormal_thyroid_physiology | 1.41652981 |
| 30 | MP0001529_abnormal_vocalization | 1.40138742 |
| 31 | MP0003121_genomic_imprinting | 1.38427580 |
| 32 | MP0004043_abnormal_pH_regulation | 1.36451355 |
| 33 | MP0005171_absent_coat_pigmentation | 1.36174082 |
| 34 | MP0001486_abnormal_startle_reflex | 1.36088052 |
| 35 | MP0002090_abnormal_vision | 1.34382059 |
| 36 | MP0000372_irregular_coat_pigmentation | 1.33362060 |
| 37 | MP0001177_atelectasis | 1.32928131 |
| 38 | MP0010352_gastrointestinal_tract_polyps | 1.31002974 |
| 39 | MP0005332_abnormal_amino_acid | 1.30560458 |
| 40 | MP0005253_abnormal_eye_physiology | 1.26926936 |
| 41 | MP0003111_abnormal_nucleus_morphology | 1.23442195 |
| 42 | MP0001299_abnormal_eye_distance/ | 1.22707054 |
| 43 | MP0003122_maternal_imprinting | 1.21024933 |
| 44 | MP0002751_abnormal_autonomic_nervous | 1.20838223 |
| 45 | MP0004147_increased_porphyrin_level | 1.20243776 |
| 46 | MP0005174_abnormal_tail_pigmentation | 1.11452262 |
| 47 | MP0003890_abnormal_embryonic-extraembry | 1.10438526 |
| 48 | MP0002295_abnormal_pulmonary_circulatio | 1.09908909 |
| 49 | MP0009046_muscle_twitch | 1.09327307 |
| 50 | MP0002557_abnormal_social/conspecific_i | 1.08212701 |
| 51 | MP0002822_catalepsy | 1.05400042 |
| 52 | MP0003123_paternal_imprinting | 1.05081931 |
| 53 | MP0005395_other_phenotype | 1.02053249 |
| 54 | MP0003119_abnormal_digestive_system | 1.00084389 |
| 55 | MP0009703_decreased_birth_body | 0.99315877 |
| 56 | MP0002736_abnormal_nociception_after | 0.98951160 |
| 57 | MP0003787_abnormal_imprinting | 0.97883463 |
| 58 | MP0002184_abnormal_innervation | 0.97397121 |
| 59 | MP0008057_abnormal_DNA_replication | 0.96620512 |
| 60 | MP0003186_abnormal_redox_activity | 0.95175524 |
| 61 | MP0009697_abnormal_copulation | 0.93354405 |
| 62 | MP0001324_abnormal_eye_pigmentation | 0.91604733 |
| 63 | MP0003937_abnormal_limbs/digits/tail_de | 0.88410690 |
| 64 | MP0002272_abnormal_nervous_system | 0.86186876 |
| 65 | MP0002837_dystrophic_cardiac_calcinosis | 0.85120039 |
| 66 | MP0005248_abnormal_Harderian_gland | 0.84614014 |
| 67 | MP0000778_abnormal_nervous_system | 0.82832146 |
| 68 | MP0001666_abnormal_nutrient_absorption | 0.82790363 |
| 69 | MP0001286_abnormal_eye_development | 0.82244356 |
| 70 | MP0000427_abnormal_hair_cycle | 0.81736218 |
| 71 | MP0005075_abnormal_melanosome_morpholog | 0.78913329 |
| 72 | MP0003011_delayed_dark_adaptation | 0.78373272 |
| 73 | MP0006276_abnormal_autonomic_nervous | 0.77078666 |
| 74 | MP0004215_abnormal_myocardial_fiber | 0.76813718 |
| 75 | MP0009672_abnormal_birth_weight | 0.76558422 |
| 76 | MP0003195_calcinosis | 0.76444254 |
| 77 | MP0000647_abnormal_sebaceous_gland | 0.76250289 |
| 78 | MP0003693_abnormal_embryo_hatching | 0.75985747 |
| 79 | MP0005195_abnormal_posterior_eye | 0.74778593 |
| 80 | MP0002095_abnormal_skin_pigmentation | 0.73888485 |
| 81 | MP0002067_abnormal_sensory_capabilities | 0.72412200 |
| 82 | MP0004957_abnormal_blastocyst_morpholog | 0.72036081 |
| 83 | MP0002102_abnormal_ear_morphology | 0.71716695 |
| 84 | MP0000631_abnormal_neuroendocrine_gland | 0.71379005 |
| 85 | MP0001968_abnormal_touch/_nociception | 0.70672311 |
| 86 | MP0005391_vision/eye_phenotype | 0.69236124 |
| 87 | MP0000579_abnormal_nail_morphology | 0.67737731 |
| 88 | MP0008007_abnormal_cellular_replicative | 0.67501635 |
| 89 | MP0005645_abnormal_hypothalamus_physiol | 0.65983235 |
| 90 | MP0004133_heterotaxia | 0.65275504 |
| 91 | MP0002697_abnormal_eye_size | 0.61588420 |
| 92 | MP0002752_abnormal_somatic_nervous | 0.61390002 |
| 93 | MP0008569_lethality_at_weaning | 0.61128446 |
| 94 | MP0000566_synostosis | 0.59509357 |
| 95 | MP0006036_abnormal_mitochondrial_physio | 0.56418844 |
| 96 | MP0005636_abnormal_mineral_homeostasis | 0.56398515 |
| 97 | MP0002069_abnormal_eating/drinking_beha | 0.54663563 |
| 98 | MP0003786_premature_aging | 0.53902743 |
| 99 | MP0005408_hypopigmentation | 0.53313022 |
| 100 | MP0005187_abnormal_penis_morphology | 0.52996001 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypobetalipoproteinemia (HP:0003563) | 8.61470562 |
| 2 | Hyperlipoproteinemia (HP:0010980) | 5.42350669 |
| 3 | Hypolipoproteinemia (HP:0010981) | 5.36464685 |
| 4 | Hyperglycinemia (HP:0002154) | 5.21946945 |
| 5 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.10832658 |
| 6 | Abnormality of the labia minora (HP:0012880) | 4.01552387 |
| 7 | Malnutrition (HP:0004395) | 4.00291532 |
| 8 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.98726541 |
| 9 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 3.51518278 |
| 10 | Colon cancer (HP:0003003) | 3.42062318 |
| 11 | Abnormality of glycine metabolism (HP:0010895) | 3.28052485 |
| 12 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.28052485 |
| 13 | Chromsome breakage (HP:0040012) | 3.23839946 |
| 14 | Abnormality of chromosome stability (HP:0003220) | 3.12444598 |
| 15 | Hypomagnesemia (HP:0002917) | 3.00780771 |
| 16 | Abnormality of serum amino acid levels (HP:0003112) | 2.92005922 |
| 17 | Type 2 muscle fiber atrophy (HP:0003554) | 2.91074505 |
| 18 | Hyperglycinuria (HP:0003108) | 2.87034872 |
| 19 | Meckel diverticulum (HP:0002245) | 2.79887245 |
| 20 | Abolished electroretinogram (ERG) (HP:0000550) | 2.77919380 |
| 21 | Pendular nystagmus (HP:0012043) | 2.76827717 |
| 22 | Proximal tubulopathy (HP:0000114) | 2.75449539 |
| 23 | Abnormality of the ileum (HP:0001549) | 2.74138097 |
| 24 | Nausea (HP:0002018) | 2.67472905 |
| 25 | Abnormality of methionine metabolism (HP:0010901) | 2.65046386 |
| 26 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.60125815 |
| 27 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 2.56074920 |
| 28 | Methylmalonic acidemia (HP:0002912) | 2.54899940 |
| 29 | Hepatoblastoma (HP:0002884) | 2.51248485 |
| 30 | Volvulus (HP:0002580) | 2.46054936 |
| 31 | Pigmentary retinal degeneration (HP:0001146) | 2.42154183 |
| 32 | Abnormality of the preputium (HP:0100587) | 2.40737867 |
| 33 | Bicornuate uterus (HP:0000813) | 2.39650927 |
| 34 | Hypoalphalipoproteinemia (HP:0003233) | 2.35562926 |
| 35 | Neoplasm of the adrenal cortex (HP:0100641) | 2.30226156 |
| 36 | Intestinal atresia (HP:0011100) | 2.27747378 |
| 37 | Muscle fiber atrophy (HP:0100295) | 2.25775993 |
| 38 | Methylmalonic aciduria (HP:0012120) | 2.24963933 |
| 39 | Abnormality of vitamin B metabolism (HP:0004340) | 2.24433493 |
| 40 | Dyschromatopsia (HP:0007641) | 2.24300574 |
| 41 | Tetany (HP:0001281) | 2.23279642 |
| 42 | Spontaneous abortion (HP:0005268) | 2.20466227 |
| 43 | Neoplasm of the oral cavity (HP:0100649) | 2.18975998 |
| 44 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.18739972 |
| 45 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 2.17662789 |
| 46 | Abnormality of magnesium homeostasis (HP:0004921) | 2.15985084 |
| 47 | Neoplasm of the adrenal gland (HP:0100631) | 2.09902221 |
| 48 | Decreased muscle mass (HP:0003199) | 2.08278749 |
| 49 | Stenosis of the external auditory canal (HP:0000402) | 2.07662902 |
| 50 | Severe Myopia (HP:0011003) | 2.06197040 |
| 51 | Small intestinal stenosis (HP:0012848) | 2.05217585 |
| 52 | Duodenal stenosis (HP:0100867) | 2.05217585 |
| 53 | Oligodactyly (hands) (HP:0001180) | 2.01829711 |
| 54 | Chronic hepatic failure (HP:0100626) | 1.99885889 |
| 55 | Impulsivity (HP:0100710) | 1.99652312 |
| 56 | Papillary thyroid carcinoma (HP:0002895) | 1.99366268 |
| 57 | Tubulointerstitial nephritis (HP:0001970) | 1.97071514 |
| 58 | Nephroblastoma (Wilms tumor) (HP:0002667) | 1.96519373 |
| 59 | Truncal obesity (HP:0001956) | 1.95464206 |
| 60 | Abnormal lung lobation (HP:0002101) | 1.94384919 |
| 61 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.94150579 |
| 62 | Genital tract atresia (HP:0001827) | 1.94096572 |
| 63 | Abnormal hair whorl (HP:0010721) | 1.94014896 |
| 64 | Delayed CNS myelination (HP:0002188) | 1.92259406 |
| 65 | Stomach cancer (HP:0012126) | 1.91767985 |
| 66 | Abnormality of the duodenum (HP:0002246) | 1.91130582 |
| 67 | Bifid tongue (HP:0010297) | 1.90248354 |
| 68 | Pancreatic cysts (HP:0001737) | 1.87928924 |
| 69 | Septo-optic dysplasia (HP:0100842) | 1.86902004 |
| 70 | Choroideremia (HP:0001139) | 1.85370859 |
| 71 | Absent radius (HP:0003974) | 1.84698179 |
| 72 | Fair hair (HP:0002286) | 1.83665443 |
| 73 | Abnormality of the carotid arteries (HP:0005344) | 1.83238303 |
| 74 | Vaginal atresia (HP:0000148) | 1.82830161 |
| 75 | True hermaphroditism (HP:0010459) | 1.80476858 |
| 76 | Embryonal renal neoplasm (HP:0011794) | 1.78515331 |
| 77 | Abnormality of the astrocytes (HP:0100707) | 1.76909163 |
| 78 | Astrocytoma (HP:0009592) | 1.76909163 |
| 79 | Aplasia/Hypoplasia of the sternum (HP:0006714) | 1.75185842 |
| 80 | Congenital sensorineural hearing impairment (HP:0008527) | 1.74291503 |
| 81 | Hyperventilation (HP:0002883) | 1.72670143 |
| 82 | Absent forearm bone (HP:0003953) | 1.72013906 |
| 83 | Aplasia involving forearm bones (HP:0009822) | 1.72013906 |
| 84 | Birth length less than 3rd percentile (HP:0003561) | 1.70731848 |
| 85 | Abnormality of vitamin metabolism (HP:0100508) | 1.70278927 |
| 86 | Abnormality of midbrain morphology (HP:0002418) | 1.70192117 |
| 87 | Molar tooth sign on MRI (HP:0002419) | 1.70192117 |
| 88 | Absent hair (HP:0002298) | 1.69486775 |
| 89 | Clubbing of toes (HP:0100760) | 1.69220718 |
| 90 | Hypothermia (HP:0002045) | 1.68323647 |
| 91 | Vacuolated lymphocytes (HP:0001922) | 1.67626398 |
| 92 | Pancreatic fibrosis (HP:0100732) | 1.65758779 |
| 93 | Epidermoid cyst (HP:0200040) | 1.65087938 |
| 94 | Drooling (HP:0002307) | 1.63977871 |
| 95 | Abnormality of macular pigmentation (HP:0008002) | 1.63837808 |
| 96 | Joint hemorrhage (HP:0005261) | 1.63501905 |
| 97 | Acute encephalopathy (HP:0006846) | 1.62642914 |
| 98 | Fatigable weakness (HP:0003473) | 1.62554976 |
| 99 | Abnormality of the neuromuscular junction (HP:0003398) | 1.62554976 |
| 100 | Absent eyebrow (HP:0002223) | 1.62344701 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MUSK | 5.95523223 |
| 2 | PIK3CG | 5.38884401 |
| 3 | WNK3 | 4.01536398 |
| 4 | MKNK2 | 3.07519318 |
| 5 | TNIK | 2.89896615 |
| 6 | ACVR1B | 2.85521824 |
| 7 | MAP3K4 | 2.82487569 |
| 8 | TRIM28 | 2.63277985 |
| 9 | CASK | 2.55980767 |
| 10 | FRK | 2.51872281 |
| 11 | BUB1 | 2.16020876 |
| 12 | MAP2K7 | 2.15166212 |
| 13 | MKNK1 | 2.10569797 |
| 14 | NEK1 | 2.07818433 |
| 15 | BMPR1B | 2.04901857 |
| 16 | BCKDK | 1.95788268 |
| 17 | MAP3K6 | 1.92945792 |
| 18 | TSSK6 | 1.63549109 |
| 19 | NUAK1 | 1.55778038 |
| 20 | FGFR2 | 1.54634940 |
| 21 | PLK4 | 1.54572603 |
| 22 | GRK1 | 1.51703961 |
| 23 | MAP4K2 | 1.49068577 |
| 24 | NME1 | 1.38911185 |
| 25 | PBK | 1.37079007 |
| 26 | EPHA4 | 1.36513681 |
| 27 | ZAK | 1.26200491 |
| 28 | CDC7 | 1.23123954 |
| 29 | NLK | 1.15585145 |
| 30 | TESK2 | 1.13761648 |
| 31 | CSNK1G2 | 1.11581135 |
| 32 | PLK3 | 1.08803054 |
| 33 | TTK | 1.06465808 |
| 34 | MST4 | 1.02952986 |
| 35 | SRPK1 | 1.01320802 |
| 36 | BRSK2 | 0.99340138 |
| 37 | TAF1 | 0.98401589 |
| 38 | MAP2K4 | 0.96970773 |
| 39 | ADRBK2 | 0.92994125 |
| 40 | CSNK1G1 | 0.92614500 |
| 41 | AKT3 | 0.91105236 |
| 42 | PLK1 | 0.81862584 |
| 43 | PRKCG | 0.78885424 |
| 44 | FGFR1 | 0.77985400 |
| 45 | PRKCE | 0.75882561 |
| 46 | WEE1 | 0.73640482 |
| 47 | PAK3 | 0.72831822 |
| 48 | DYRK2 | 0.72777335 |
| 49 | VRK1 | 0.72120239 |
| 50 | MARK1 | 0.71645174 |
| 51 | ERBB3 | 0.70938261 |
| 52 | DYRK3 | 0.70498932 |
| 53 | EIF2AK3 | 0.67021753 |
| 54 | CSNK1A1L | 0.62603389 |
| 55 | CSNK1G3 | 0.61940904 |
| 56 | TGFBR1 | 0.61936979 |
| 57 | BCR | 0.58520021 |
| 58 | STK38L | 0.51312267 |
| 59 | UHMK1 | 0.50938523 |
| 60 | STK39 | 0.49934573 |
| 61 | MAPK13 | 0.49264783 |
| 62 | PDK2 | 0.48900778 |
| 63 | VRK2 | 0.47101403 |
| 64 | PLK2 | 0.44983525 |
| 65 | OXSR1 | 0.44747967 |
| 66 | SGK2 | 0.42438796 |
| 67 | ATM | 0.39580247 |
| 68 | ERBB4 | 0.39451177 |
| 69 | ALK | 0.37177490 |
| 70 | PRKACB | 0.37166255 |
| 71 | INSRR | 0.36148795 |
| 72 | SGK494 | 0.35856694 |
| 73 | SGK223 | 0.35856694 |
| 74 | ATR | 0.35853798 |
| 75 | TIE1 | 0.35540999 |
| 76 | EPHA3 | 0.33766716 |
| 77 | FGR | 0.31965660 |
| 78 | CHEK1 | 0.31778918 |
| 79 | MAP3K5 | 0.31761666 |
| 80 | CDK3 | 0.31501135 |
| 81 | FER | 0.30458040 |
| 82 | CDK19 | 0.29931478 |
| 83 | MARK3 | 0.27956752 |
| 84 | AURKB | 0.27644415 |
| 85 | CSNK1D | 0.26951690 |
| 86 | EIF2AK2 | 0.25758559 |
| 87 | PRKCB | 0.25529388 |
| 88 | PRKDC | 0.25245306 |
| 89 | PINK1 | 0.24680919 |
| 90 | CSNK1E | 0.24519667 |
| 91 | MAP3K12 | 0.24446186 |
| 92 | YES1 | 0.24123151 |
| 93 | CAMK2A | 0.23692837 |
| 94 | CSNK2A1 | 0.21640521 |
| 95 | MYLK | 0.21424050 |
| 96 | RPS6KA4 | 0.21415535 |
| 97 | CHEK2 | 0.21300511 |
| 98 | OBSCN | 0.20905410 |
| 99 | PTK2B | 0.20517900 |
| 100 | CDK1 | 0.20459838 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 5.00778436 |
| 2 | Selenocompound metabolism_Homo sapiens_hsa00450 | 2.50529403 |
| 3 | Fat digestion and absorption_Homo sapiens_hsa04975 | 2.46174417 |
| 4 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 2.26294363 |
| 5 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.25450528 |
| 6 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.23970624 |
| 7 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 2.18476718 |
| 8 | Galactose metabolism_Homo sapiens_hsa00052 | 2.16612513 |
| 9 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.15364954 |
| 10 | Non-homologous end-joining_Homo sapiens_hsa03450 | 2.13776187 |
| 11 | Mineral absorption_Homo sapiens_hsa04978 | 2.07821640 |
| 12 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.07210215 |
| 13 | Nicotine addiction_Homo sapiens_hsa05033 | 2.00688412 |
| 14 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.98565206 |
| 15 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.94891721 |
| 16 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.83575185 |
| 17 | Mismatch repair_Homo sapiens_hsa03430 | 1.80183441 |
| 18 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.72564872 |
| 19 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.71118736 |
| 20 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.70731635 |
| 21 | Homologous recombination_Homo sapiens_hsa03440 | 1.64969479 |
| 22 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.61107198 |
| 23 | Proteasome_Homo sapiens_hsa03050 | 1.60473221 |
| 24 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.58178949 |
| 25 | Basal transcription factors_Homo sapiens_hsa03022 | 1.56344773 |
| 26 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.51365561 |
| 27 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.50267032 |
| 28 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.45775643 |
| 29 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.43554035 |
| 30 | RNA polymerase_Homo sapiens_hsa03020 | 1.43083750 |
| 31 | Protein export_Homo sapiens_hsa03060 | 1.41849000 |
| 32 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.41491776 |
| 33 | DNA replication_Homo sapiens_hsa03030 | 1.38439422 |
| 34 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.34446925 |
| 35 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.32217134 |
| 36 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.27103605 |
| 37 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.25532421 |
| 38 | Parkinsons disease_Homo sapiens_hsa05012 | 1.24023143 |
| 39 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.23359211 |
| 40 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.22090930 |
| 41 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.13009982 |
| 42 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.10446326 |
| 43 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.09721634 |
| 44 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.07707817 |
| 45 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.06270987 |
| 46 | RNA degradation_Homo sapiens_hsa03018 | 1.05513623 |
| 47 | Huntingtons disease_Homo sapiens_hsa05016 | 1.01183246 |
| 48 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.00576663 |
| 49 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.98966339 |
| 50 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.98529064 |
| 51 | Purine metabolism_Homo sapiens_hsa00230 | 0.97902234 |
| 52 | Phototransduction_Homo sapiens_hsa04744 | 0.97028018 |
| 53 | RNA transport_Homo sapiens_hsa03013 | 0.96717055 |
| 54 | Retinol metabolism_Homo sapiens_hsa00830 | 0.95856161 |
| 55 | Carbon metabolism_Homo sapiens_hsa01200 | 0.94032943 |
| 56 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.92959108 |
| 57 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.92788714 |
| 58 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.91275279 |
| 59 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.85610940 |
| 60 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.84897193 |
| 61 | Metabolic pathways_Homo sapiens_hsa01100 | 0.73019982 |
| 62 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.68615494 |
| 63 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.66206438 |
| 64 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.65226666 |
| 65 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.64658879 |
| 66 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.64204129 |
| 67 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.63318257 |
| 68 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.61397774 |
| 69 | Taste transduction_Homo sapiens_hsa04742 | 0.61068062 |
| 70 | Cell cycle_Homo sapiens_hsa04110 | 0.60829342 |
| 71 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.60739843 |
| 72 | Spliceosome_Homo sapiens_hsa03040 | 0.60680136 |
| 73 | Alzheimers disease_Homo sapiens_hsa05010 | 0.57098663 |
| 74 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.57082907 |
| 75 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.56598279 |
| 76 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.56030569 |
| 77 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.55818025 |
| 78 | Histidine metabolism_Homo sapiens_hsa00340 | 0.55654966 |
| 79 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.54264400 |
| 80 | Peroxisome_Homo sapiens_hsa04146 | 0.53796346 |
| 81 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.53347052 |
| 82 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.50919095 |
| 83 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.49836658 |
| 84 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.48875689 |
| 85 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.47992771 |
| 86 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.47030158 |
| 87 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.45818483 |
| 88 | Morphine addiction_Homo sapiens_hsa05032 | 0.44854026 |
| 89 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.44747258 |
| 90 | Tight junction_Homo sapiens_hsa04530 | 0.43994843 |
| 91 | GABAergic synapse_Homo sapiens_hsa04727 | 0.41346869 |
| 92 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.40536725 |
| 93 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.36000265 |
| 94 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.35306447 |
| 95 | Salivary secretion_Homo sapiens_hsa04970 | 0.33989769 |
| 96 | Lysine degradation_Homo sapiens_hsa00310 | 0.33586930 |
| 97 | Bile secretion_Homo sapiens_hsa04976 | 0.33059627 |
| 98 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.32663488 |
| 99 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.31064942 |
| 100 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.27061579 |

